original ) (raw )Intensity-modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status
Mathew Meeneghan , Paul Read
Cancer, 2010
View PDFchevron_right
Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer
Bruce Haughey
The Laryngoscope, 2012
View PDFchevron_right
Evaluation of pathologic staging using number of nodes in p16-negative head and neck cancer
B. Abedi
Oral Oncology, 2020
View PDFchevron_right
Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality
Markus Wolfensberger
International Journal of Cancer, 2009
View PDFchevron_right
Neck dissection followed by chemoradiotherapy for stage IV (N+) oropharynx cancer
Rita Axelrod
Otolaryngology - Head and Neck Surgery, 2007
View PDFchevron_right
Highlights in Head and Neck Cancer
Pol Specenier
JAMA Oncology, 2017
View PDFchevron_right
Changing trends in the management of the neck in oropharyngeal squamous cell carcinoma
Hesham Mohamed
Head & neck, 2017
View PDFchevron_right
Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer
Suzanne Wolden
International Journal of Cancer, 2013
View PDFchevron_right
Regional control after concomitant chemoradiotherapy without planned neck dissection in node-positive head and neck squamous cell carcinomas
Takatsugu Mizumachi , Kazuhiko Tsuchiya , Tomohiro Sakashita , Nobuhiko Oridate
Auris Nasus Larynx, 2013
View PDFchevron_right
Delayed lymph node metastases after elective neck dissection in patients with oral and oropharyngeal cancer and pN0 neck
Ayotunde Fasunla
American Journal of Otolaryngology, 2012
View PDFchevron_right
P16 Cutoff in Head and Neck Squamous Cell Carcinoma: Correlation Between Tumor and Patient Characteristics and Outcome
Daniela Vivenza
The International journal of biological markers, 2015
View PDFchevron_right
Prognostic Significance of p16INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
Quynh-thu Le
Journal of Clinical Oncology, 2010
View PDFchevron_right
Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease
Giuseppe Mercante , Raul Pellini
Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2014
View PDFchevron_right
P16 Expression in Oropharyngeal Cancer: Its Impact on Staging and Prognosis Compared with the Conventional Clinical Staging Parameters
Luigi Tornillo
Annals of Oncology, 2010
View PDFchevron_right
CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy
Steven Chinn
Radiotherapy and Oncology, 2021
View PDFchevron_right
Neck dissection after chemoradiotherapy for oropharyngeal and hypopharyngeal cancer: the correlation between cervical lymph node metastasis and prognosis
Takeshi Kodaira
International Journal of Clinical Oncology, 2014
View PDFchevron_right
Predicting Residual Neck Disease in Patients With Oropharyngeal Squamous Cell Carcinoma Treated With Radiation Therapy
Asal Rahimi
Archives of Otolaryngology–Head & Neck Surgery, 2009
View PDFchevron_right
Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer
Shubhada Kane
The New England Journal of Medicine, 2015
View PDFchevron_right
Is there a role for selective neck dissection after chemoradiation for head and neck cancer?
Patrick Bradley
Journal of the American College of Surgeons, 2004
View PDFchevron_right
Induction Chemotherapy for p16 Positive Oropharyngeal Squamous Cell Carcinoma
Tatsuya Yamasoba
Laryngoscope Investigative Otolaryngology
View PDFchevron_right
Management of clinically N0 neck in oropharyngeal carcinoma
Timo Atula
European Archives of Oto-Rhino-Laryngology, 2019
View PDFchevron_right
Cisplatin-based chemoradiotherapy vs. cetuximab-based bioradiotherapy for p16-positive oropharyngeal cancer: an updated meta-analysis including trials RTOG 1016 and De-ESCALaTE
Ivica Lukšić
European Archives of Oto-Rhino-Laryngology, 2019
View PDFchevron_right
Role of neck dissection following concurrent chemoradiation for advanced head and neck carcinoma
Marie-jo Olivier
Head & Neck, 2006
View PDFchevron_right
Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?
Ramon Esclamado
Head & Neck, 2003
View PDFchevron_right
The role of initial neck dissection for patients with node-positive oropharyngeal squamous cell carcinomas
Tomohiro Sakashita
Oral Oncology, 2014
View PDFchevron_right
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes, NRG Oncology/RTOG 9501-0234
Robert Foote
Journal of Clinical Oncology, 2015
View PDFchevron_right
Prognostic Value of Pathologically Positive Nodal Number in p16-Negative Oropharyngeal and Hypopharyngeal Squamous Cell Carcinoma with pN3b Status
Fu-min Fang
Diagnostics
View PDFchevron_right
Extracapsular extension of neck nodes and absence of human papillomavirus 16‐DNA are predictors of impaired survival in p16‐positive oropharyngeal squamous cell carcinoma
Gunnar Wichmann
Cancer
View PDFchevron_right
p16 status of oropharyngeal and oral cavity squamous cell carcinomas: A single institution experience
Aleksandar Trivic
Srpski arhiv za celokupno lekarstvo
View PDFchevron_right